Yatham Lakshmi N
Division of Mood Disorders, University of British Columbia, Vancouver, Canada.
J Clin Psychiatry. 2005;66 Suppl 1:13-7.
Bipolar II disorder is frequently misdiagnosed as major depressive disorder. In particular, correct diagnosis of bipolar II disorder may be delayed by years due to the predominance of depressive symptoms and the relative subtlety of hypomania, which may manifest only briefly and without elevated mood. The prevalence of bipolar II disorder varies from 0.5% to about 5% depending on the criteria used. Diagnosis can be improved by using mood disorder questionnaires, systematic probing, and prospective mood diary charting. There is a dearth of research into treatment of bipolar disorder. The limited available evidence suggests that lithium and lamotrigine may have efficacy in preventing relapse of mood episodes. Acute bipolar II depression could be treated with a combination of a mood stabilizer plus an antidepressant or pramipexole and in rare cases with antidepressant monotherapy. Hypomania will likely respond to monotherapy with antimanic agents. Adjunctive psychosocial treatments may provide additional benefit in patients with bipolar II disorder.
双相II型障碍常被误诊为重度抑郁症。特别是,由于抑郁症状占主导以及轻躁狂相对不明显(可能仅短暂出现且无情绪高涨),双相II型障碍的正确诊断可能会延迟数年。根据所使用的标准,双相II型障碍的患病率在0.5%至约5%之间。使用情绪障碍问卷、系统探查和前瞻性情绪日记记录有助于改善诊断。关于双相障碍治疗的研究匮乏。有限的现有证据表明,锂盐和拉莫三嗪可能对预防情绪发作复发有效。急性双相II型抑郁可采用心境稳定剂加抗抑郁药或普拉克索联合治疗,在极少数情况下可采用抗抑郁药单药治疗。轻躁狂可能对抗躁狂药物单药治疗有反应。辅助性心理社会治疗可能对双相II型障碍患者有额外益处。